Stories

Vaping is under scrutiny for its potential link to oral cancer and other health risks such as genotoxicity and oxidative stress. Although research from 2023 points to certain chemicals in e-cigarettes as carcinogenic and capable of causing oral cancer, the exact connection is still unclear. Flavored e-cigarettes may encourage long-term use, heightening risks. Nicotine addiction, especially in young users, is a concern. Further studies are needed to fully grasp the long-term effects of vaping on health.

In this episode of Vaping Unplugged, we're joined by the one and only Ivan Bik – a renowned podcaster and outspoken advocate for harm reduction. Ivan brings his signature energy and insight as we dive into the current state of THR in the Netherlands. What’s happening? How are consumers reacting to flavor restrictions? What does the future look like for harm reduction in the Netherlands?

A new study from the University of California - Riverside warns that menthol-flavored e-cigarettes may pose risks to fetal development. Published in STEM CELLS Translational Medicine, the research found that even low concentrations of menthol can disrupt key cellular processes in embryos. Many pregnant women turn to e-cigarettes as a safer alternative to tobacco, but the study suggests that menthol exposure may still be harmful. Researchers discovered that menthol activates stress-related channels in the blood, which play a role in various bodily functions, potentially affecting the unborn child.

A recent umbrella review by CoEHAR found no short or medium-term respiratory impact from vaping, regardless of usage patterns. Led by Dr. La Rosa, Prof. Polosa, and Dr. O'Leary, the analysis of 12 systematic reviews noted no significant changes in lung function across different user categories. Acute studies suggest no respiratory variations in the short or medium term, but longitudinal data is lacking. Despite limitations in study quality and inconsistencies in past research, vaping is not associated with notable respiratory changes. This study builds on previous CoEHAR research indicating no increase in respiratory symptoms from vaping, specifically among non-smokers.

A leaked European Commission document reveals plans for a significant EU-wide tax increase on white snus, potentially causing economic, political, and criminal consequences. Published by Snusjournalen, the directive is driven by the Directorate-General for Taxation and Customs Union (DG TAXUD). The leak emerges amid Europe's economic struggles, with persistent inflation, slow growth, and rising tensions with the U.S., which recently imposed new tariffs on EU-made vehicles. Critics argue that the proposed tax could further burden consumers and discourage investment in EU production.

English football players have been using white snus, a tobacco-free nicotine product, to enhance performance. While this trend is popularized through social media influencers, its health effects remain unclear. Marketed as a clean alternative to smoking, white snus is misleadingly labeled as tobacco-free when it contains nicotine derived from tobacco leaves. Despite claims of being a healthier nicotine option, its risks are not thoroughly studied. Young people are especially vulnerable to nicotine addiction and potential negative impacts on health, including brain development. Little independent research exists on white snus, emphasizing the need for further investigation into its long-term health implications.

India has banned e-cigarette sales to protect its young population, with 27% of Indians using tobacco. The misconception that e-cigarettes help quit smoking is false. The ban restricts production, sale, and advertisement of e-cigarettes, aiming to address health concerns. Vaping exposes users to harmful substances like nicotine and metals. Contrary to belief, vaping does not produce water vapor but an aerosol with health risks. The effects of vaping on lungs can be severe, causing EVALI and potentially fatal consequences. Quitting smoking is more effectively achieved through approved methods like patches and counseling, rather than vaping.

Living on the streets during the HIV/AIDS epidemic, the narrator faced challenges with injecting meth, sharing needles, and preventing transmission. Access to sterile equipment in 1992 improved harm reduction efforts. Prioritizing easy, enjoyable harm reduction methods, such as using new rigs or flavored vapes, can save lives. Offering accessible resources, like flavored nicotine products and harm reduction centers, can effectively reduce risks. The importance of supporting safer choices, such as managing substance use through pleasurable adjustments, is highlighted. Emphasizing convenience and pleasure in harm reduction strategies can lead to better outcomes, as seen with snus uptake in Sweden. The need for accessible harm reduction resources, like methadone, is crucial to reduce drug-related harms and save lives.

MPs have approved the Tobacco and Vapes Bill in the UK, aiming to create a smoke-free generation by gradually raising the legal smoking age and regulating vaping products to protect youth. The bill bans under-18s from buying nicotine products, restricts vape advertising, and prohibits smoking near schools and hospitals. The proposal also includes plans to regulate vape packaging and flavors to prevent appeal to children. Despite opposition, the bill passed in the House of Commons, focusing on reducing smoking and youth vaping. The bill will face further review in the House of Lords.

French oncologist David Khayat advocates for harm reduction strategies in tobacco control, arguing that alternative smoking methods reduce cancer risk by minimizing exposure to harmful substances. He highlights the inefficacy of traditional anti-smoking policies and emphasizes the need for regulatory frameworks supporting smoke-free technologies. Khayat stresses the importance of balancing smoking cessation efforts with harm reduction, aiming to transition smokers away from cigarettes. He criticizes the World Health Organization's opposition to harm reduction and urges policymakers to consider evidence supporting reduced-risk products. As global discussions on tobacco control evolve, the focus on harm reduction is expected to intensify at the upcoming WHO conference in November.